top of page

C2C
Title: C2C: COMBINE-2 for Cabotegravir+Rilpivirine LA Regimen - A Prospective Cohort Study to Monitor Effectiveness, Adherence and Resistance
Sites: Ongoing
Territories: UK, Belgium, France, Germany, Italy, Netherlands, Spain, Switzerland & Sweden
Status: Ongoing, open to recruitment
bottom of page